Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Latest Updates |
|
|
Pharma Bosses See Inflation As The No. 1 Challenge In 2023
Over the course of 2022, officials in the industry have grown increasingly concerned about the increasing costs of operations in the pharmaceutical sector.
|
|
|
|
|
|
|
|
|
|
Technology Growth In The Biopharma Outsourcing Industry
CMOs want to increase outsourcing to high levels in several areas, placing particular emphasis on testing, analysis, drug screening, and fill-finish activities.
|
|
|
|
|
|
Australia Implements New Measure To Lower Cost of Medicines
Since the top co-payment is decreasing from $42.50 to $30, millions of Australians will pay up to 29% less for their Pharma Benefits Scheme- PBS medicines.
|
|
|
|
|
|
|
|
|
|
FDA Drug Nods Dip To 37 In 2022 From 51- A Median Since 2017
Though industry news sites try to keep up with complete response letters, agency does not post them, and there is evidence to show that FDA is clamping down.
|
|
|
|
|
|
|
Research Inside |
|
|
Finding Drugs That Fight Bacteria With Multi-Drug Resistance
Researchers have identified chemical variants of novel antibiotic successful in battling multi-drug resistant bacteria and, as a result, serious infections.
|
|
|
|
|
|
|
|
|
|
Antibiotic Resistance Being Weakened By Persistent Bacteria
Understanding how bacteria might adapt to withstanding the antibiotic treatment may be possible thanks to a novel phenomenon known as bacterial perseverance.
|
|
|
|
|
|
Novel Method To Stop Antibody From Blocking Transplant Cells
In the fresh concept, a baited trap receptor is used to catch the antibodies and remove them from the system before they can destroy the therapeutic cells.
|
|
|
|
|